TKT Hemophilia Gene Therapy Trial Halted Despite No Evidence Of Problems

The suspension of Transkaryotic Therapies' gene therapy trial at Beth Israel Deaconess Medical Center could signal the beginning of a trend of gene therapy trial suspensions as a cautionary measure even if the study shows no sign of problems.